168 related articles for article (PubMed ID: 30307688)
1. Age at diagnosis and the surgical management of small renal carcinomas: findings from a cross-sectional population-based study.
White VM; Marco DJT; Bolton D; Papa N; Neale RE; Coory M; Davis ID; Wood S; Giles GG; Jordan SJ
BJU Int; 2018 Nov; 122 Suppl 5():50-61. PubMed ID: 30307688
[TBL] [Abstract][Full Text] [Related]
2. Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States.
Banegas MP; Harlan LC; Mann B; Yabroff KR
Urol Oncol; 2016 Oct; 34(10):433.e9-433.e17. PubMed ID: 27321355
[TBL] [Abstract][Full Text] [Related]
3. Contemporary management of renal cell carcinoma (RCC) in Victoria: implications for longer term outcomes and costs.
Ta AD; Bolton DM; Dimech MK; White V; Davis ID; Coory M; Millar J; Giles G
BJU Int; 2013 Nov; 112 Suppl 2():36-43. PubMed ID: 24127675
[TBL] [Abstract][Full Text] [Related]
4. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
5. Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project).
Schiavina R; Mari A; Bianchi L; Amparore D; Antonelli A; Artibani W; Brunocilla E; Capitanio U; Fiori C; Di Maida F; Gontero P; Larcher A; Li Marzi V; Longo N; Marra G; Montanari E; Porpiglia F; Roscigno M; Simeone C; Siracusano S; Tellini R; Terrone C; Villari D; Ficarra V; Carini M; Minervini A;
Eur J Surg Oncol; 2020 Jul; 46(7):1353-1359. PubMed ID: 32007380
[TBL] [Abstract][Full Text] [Related]
6. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
[TBL] [Abstract][Full Text] [Related]
7. What is the hospital volume threshold to optimize inpatient complication rate after partial nephrectomy?
Arora S; Keeley J; Pucheril D; Menon M; Rogers CG
Urol Oncol; 2018 Jul; 36(7):339.e17-339.e23. PubMed ID: 29773492
[TBL] [Abstract][Full Text] [Related]
8. Predictors of new-onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: An Australian population-based analysis.
Ahn T; Ellis RJ; White VM; Bolton DM; Coory MD; Davis ID; Francis RS; Giles GG; Gobe GC; Hawley CM; Johnson DW; Marco DJT; McStea M; Neale RE; Pascoe EM; Wood ST; Jordan SJ;
J Surg Oncol; 2018 Jun; 117(7):1597-1610. PubMed ID: 29790163
[TBL] [Abstract][Full Text] [Related]
9. Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electively.
Broughton GJ; Clark PE; Barocas DA; Cookson MS; Smith JA; Herrell SD; Chang SS
BJU Int; 2012 Jun; 109(11):1607-13. PubMed ID: 21939493
[TBL] [Abstract][Full Text] [Related]
10. Trends in the surgical management of stage 1 renal cell carcinoma: findings from a population-based study.
White V; Marco DJT; Bolton D; Davis ID; Jefford M; Hill D; Prince HM; Millar JL; Winship IM; Coory M; Giles GG
BJU Int; 2017 Nov; 120 Suppl 3():6-14. PubMed ID: 28452170
[TBL] [Abstract][Full Text] [Related]
11. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
[TBL] [Abstract][Full Text] [Related]
12. Predictors of surgical approach for the management of renal cell carcinoma: a population-based study from New South Wales.
Patel MI; Strahan S; Bang A; Vass J; Smith DP
ANZ J Surg; 2017 Nov; 87(11):E193-E198. PubMed ID: 27283936
[TBL] [Abstract][Full Text] [Related]
13. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
[TBL] [Abstract][Full Text] [Related]
14. The Adoption of Nephron-Sparing Surgery in Europe - A Trend Analysis in Two Referral Centers from Austria and Germany.
Meyer C; Hansen J; Becker A; Schmid M; Pradel L; Strini K; Chromecki T; Jesche-Chromecki J; Fisch M; Zigeuner R; Chun FK
Urol Int; 2016; 96(3):330-6. PubMed ID: 26699625
[TBL] [Abstract][Full Text] [Related]
15. A non-cancer-related survival benefit is associated with partial nephrectomy.
Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
[TBL] [Abstract][Full Text] [Related]
16. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register.
Thorstenson A; Bergman M; Scherman-Plogell AH; Hosseinnia S; Ljungberg B; Adolfsson J; Lundstam S
Scand J Urol; 2014 Jun; 48(3):231-8. PubMed ID: 24666102
[TBL] [Abstract][Full Text] [Related]
17. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery.
Butler BP; Novick AC; Miller DP; Campbell SA; Licht MR
Urology; 1995 Jan; 45(1):34-40; discussion 40-1. PubMed ID: 7817478
[TBL] [Abstract][Full Text] [Related]
18. Clampless laparoendoscopic single-site partial nephrectomy for renal cancer with low PADUA score: technique and surgical outcomes.
Springer C; Veneziano D; Wimpissinger F; Inferrera A; Fornara P; Greco F
BJU Int; 2013 Jun; 111(7):1091-8. PubMed ID: 23360654
[TBL] [Abstract][Full Text] [Related]
19. Predicted versus observed 30-day perioperative outcomes using the ACS NSQIP surgical risk calculator in patients undergoing partial nephrectomy for renal cell carcinoma.
Blair BM; Lehman EB; Jafri SM; Kaag MG; Raman JD
Int Urol Nephrol; 2018 Jul; 50(7):1249-1256. PubMed ID: 29868938
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
